GlassScriptPhysician profile
Blake Gaither Smith
NPI 1770979221
$35,655.69
in general payments reported to CMS, 2019-2025
11 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $5,928 · 2022: $21K · 2023: $8,238 · 2024: $444 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $1,910 · Travel and Lodging: $1,660 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $1,910.18 |
| Travel and Lodging | $1,659.98 |
| Education | $304.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,269.25 | 2022-2025 | Affera Mapping System |
| Boston Scientific Corporation | $10,963.86 | 2021-2023 | S-Icd System Magnet, Watchman Access System |
| Ablacon, INC. | $7,554.64 | 2022 | |
| Biotronik INC. | $3,397.94 | 2021-2023 | |
| Abbott Laboratories | $927.37 | 2022-2024 | Ensite |
| Biosense Webster, INC. | $201.37 | 2024 | Carto 3 |
| Nobel Biocare USA | $145.51 | 2019 | |
| Altathera Pharmaceuticals LLC | $125.58 | 2024 | Sotalol Hydrochloride |
| Genzyme Corporation | $31.71 | 2025 | |
| Alnylam Pharmaceuticals INC. | $19.59 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $18.87 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.